Actively Recruiting
Clinical Characteristics and Outcomes of Patients with Premature Acute Myocardial Infarction in Serbia A Multicenter National Observational Study
Led by Cardiology Society of Serbia · Updated on 2024-12-31
1000
Participants Needed
11
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying acute myocardial infarction (heart attack) in young adults aged 45 years or younger in Serbia. This national, multicenter study combines past and ongoing data to understand the clinical, demographic, and angiographic features of these patients. The study aims to identify risk factors such as smoking, diabetes, hypertension, and genetic predispositions to improve prevention, early diagnosis, and treatment strategies for premature heart attacks. Participants diagnosed with acute myocardial infarction will have routine clinical and laboratory tests during hospitalization. Specific blood samples will be collected for advanced analyses, including genetic testing. Imaging methods like echocardiography, angiography, and specialized imaging for plaque assessment will be used. The study will monitor treatment methods, including interventions and medication use, and follow patients over time to assess outcomes. During the study, participants will provide demographic and clinical information, undergo various diagnostic procedures, and have follow-up visits to track their health status. Researchers will evaluate outcomes such as the incidence and prevalence of heart attacks, demographic characteristics, angiographic findings, and major adverse cardiovascular events during hospitalization and follow-up. Participation is voluntary, and patient data will be kept confidential.
CONDITIONS
Official Title
PRemature Acute Myocardial Infarction Register of Serbia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 64 45 years
- Clinical and laboratory diagnosis of acute myocardial infarction based on the Universal Definition of Myocardial Infarction
- Voluntary participation with signed informed consent
You will not qualify if you...
- Patients aged > 45 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
Military Medical Academy 1
Belgrade, Serbia, 11000
Actively Recruiting
2
University Hospital Center Zvezdara
Belgrade, Serbia, 11000
Actively Recruiting
3
University Hospital Center Bezanijska kosa
Belgrade, Serbia, 11080
Actively Recruiting
4
University Hospital Center Zemun
Belgrade, Serbia, 11080
Actively Recruiting
5
Military Medical Academy 2
Belgrade, Serbia
Actively Recruiting
6
General Hospital Studenica
Kraljevo, Serbia, 36000
Actively Recruiting
7
University Clinical Center Nis
Niš, Serbia, 18000
Actively Recruiting
8
Institute for cardiovascular diseases Vojvodina
Novi Sad, Serbia, 21000
Actively Recruiting
9
General Hospital Prokuplje
Prokuplje, Serbia, 18400
Actively Recruiting
10
General Hospital Vrbas
Vrbas, Serbia, 21460
Actively Recruiting
11
General Hospital Zrenjanin
Zrenjanin, Serbia, 23000
Actively Recruiting
Research Team
A
Aleksandra Djokovic, MD, PhD
S
Svetlana Apostolovic, MD, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here